|
1
|
Li X, Cui Y, Sun Z, Zhang L, Li L, Wang X,
Wu J, Fu X, Ma W, Zhang X, et al: DDGP versus SMILE in newly
diagnosed advanced natural killer/T-Cell lymphoma: A randomized
controlled, multicenter, open-label study in China. Clin Cancer
Res. 22:5223–5228. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aozasa K and Zaki MA: Epidemiology and
pathogenesis of nasal NK/T-cell lymphoma: A mini-review.
ScientificWorldJournal. 11:422–428. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ai WZ, Chang ET, Fish K, Fu K,
Weisenburger DD and Keegan TH: Racial patterns of extranodal
natural killer/T-cell lymphoma, nasal type, in California: A
population-based study. Br J Haematol. 156:626–632. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Au WY, Weisenburger DD, Intragumtornchai
T, Nakamura S, Kim WS, Sng I, Vose J, Armitage JO and Liang R;
International Peripheral T-Cell Lymphoma Project, : Clinical
differences between nasal and extranasal natural killer/T-cell
lymphoma: A study of 136 cases from the International Peripheral
T-Cell Lymphoma Project. Blood. 113:3931–3937. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Suzuki R, Suzumiya J, Yamaguchi M,
Nakamura S, Kameoka J, Kojima H, Abe M, Kinoshita T, Yoshino T,
Iwatsuki K, et al: Prognostic factors for mature natural killer
(NK) cell neoplasms: Aggressive NK cell leukemia and extranodal NK
cell lymphoma, nasal type. Ann Oncol. 21:1032–1040. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim TM, Lee SY, Jeon YK, Ryoo BY, Cho GJ,
Hong YS, Kim HJ, Kim SY, Kim CS, Kim S, et al: Clinical
heterogeneity of extranodal NK/T-cell lymphoma, nasal type: A
national survey of the Korean Cancer Study Group. Ann Oncol.
19:1477–1484. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vazquez A, Khan MN, Blake DM, Sanghvi S,
Baredes S and Eloy JA: Extranodal natural killer/T-Cell lymphoma: A
population-based comparison of sinonasal and extranasal disease.
Laryngoscope. 124:888–895. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fritz A: ICD-O-3 terminology approved for
use with cases diagnosed January 1, 2014 and after. J Registry
Manag. 40:140–143. 2013.PubMed/NCBI
|
|
9
|
Liu X, Huang E, Wang Y, He Y, Luo H, Zhong
M, Qiu D, Li C, Yang H, He G, et al: Dosimetric comparison of
helical tomotherapy, VMAT, fixed-field IMRT and 3D-conformal
radiotherapy for stage I–II nasal natural killer T-cell lymphoma.
Radiat Oncol. 12:762017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma X, Guo Y, Pang Z, Wang B, Lu H, Gu YJ
and Guo X: A randomized phase II study of CEOP with or without
semustine as induction chemotherapy in patients with stage IE/IIE
extranodal NK/T-cell lymphoma, nasal type in the upper
aerodigestive tract. Radiother Oncol. 93:492–497. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim SJ, Yang DH, Kim JS, Kwak JY, Eom HS,
Hong DS, Won JH, Lee JH, Yoon DH, Cho J, et al: Concurrent
chemoradiotherapy followed by L-asparaginase-containing
chemotherapy, VIDL, for localized nasal extranodal NK/T cell
lymphoma: CISL08-01 phase II study. Ann Hematol. 93:1895–1901.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim WS, Song SY, Ahn YC, Ko YH, Baek CH,
Kim DY, Yoon SS, Lee HG, Kang WK, Lee HJ, et al: CHOP followed by
involved field radiation: Is it optimal for localized nasal natural
killer/T-cell lymphoma? Ann Oncol. 12:349–352. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim SJ, Kim K, Kim BS, Kim CY, Suh C, Huh
J, Lee SW, Kim JS, Cho J, Lee GW, et al: Phase II trial of
concurrent radiation and weekly cisplatin followed by VIPD
chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal
NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma
study. J Clin Oncol. 27:6027–6032. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Song MK, Chung JS, Yhim HY, Lim SN, Kim
SJ, Han YH, Shim HK, Jung SH, Lee JJ and Yang DH: Tumor necrosis
and complete resection has significant impacts on survival in
patients with limited-stage upper aerodigestive tract NK/T cell
lymphoma. Oncotarget. 8:79337–79346. 2017.PubMed/NCBI
|
|
15
|
Li YX, Fang H, Liu QF, Lu J, Qi SN, Wang
H, Jin J, Wang WH, Liu YP, Song YW, et al: Clinical features and
treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer
ring. Blood. 112:3057–3064. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao DL, Fu QQ, Zhang TT, Li SL, Pan Y and
Zhai QL: Analysis of clinicopathological characteristics and
prognosis of 112 patients with primary Waldeyer's ring lymphoma.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 23:1301–1308. 2015.(In
Chinese). PubMed/NCBI
|
|
17
|
Huang JJ, Zhu YJ, Xia Y, Zhao W, Lin TY,
Jiang WQ, Huang HQ and Li ZM: A novel prognostic model for
extranodal natural killer/T-cell lymphoma. Med Oncol. 29:2183–2190.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jo JC, Yoon DH, Kim S, Lee BJ, Jang YJ,
Park CS, Huh J, Lee SW, Ryu JS and Suh C: Clinical features and
prognostic model for extranasal NK/T-cell lymphoma. Eur J Haematol.
89:103–110. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pongpruttipan T, Sukpanichnant S,
Assanasen T, Wannakrairot P, Boonsakan P, Kanoksil W, Kayasut K,
Mitarnun W, Khuhapinant A, Bunworasate U, et al: Extranodal
NK/T-cell lymphoma, nasal type, includes cases of natural killer
cell and αβ, γδ, and αβ/γδ T-cell origin: A comprehensive
clinicopathologic and phenotypic study. Am J Surg Pathol.
36:481–499. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ebied A, Thanh Huan V, Makram OM, Sang TK,
Ghorab M, Ngo HT, Iraqi A, Kamel MG, Dang TN, Vuong NL, et al: The
role of primary lymph node sites in survival and mortality
prediction in Hodgkin lymphoma: A SEER population-based
retrospective study. Cancer Med. 7:953–965. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu PP, Wang KF, Jin JT, Bi XW, Sun P,
Wang Y, Yang H, Li ZM, Jiang WQ and Xia Y: Role of radiation
therapy in primary breast diffuse large B-cell lymphoma in the
Rituximab era: A SEER database analysis. Cancer Med. 7:1845–1851.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Adams SV, Newcomb PA and Shustov AR:
Racial patterns of peripheral T-Cell lymphoma incidence and
survival in the United States. J Clin Oncol. 34:963–971. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pencina MJ and D'Agostino RB: Overall C as
a measure of discrimination in survival analysis: Model specific
population value and confidence interval estimation. Stat Med.
23:2109–2123. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Harrell FE Jr, Lee KL and Mark DB:
Multivariable prognostic models: Issues in developing models,
evaluating assumptions and adequacy, and measuring and reducing
errors. Stat Med. 15:361–387. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Niu SQ, Yang Y, Li YY, Wen G, Wang L, Li
ZM, Wang HY, Zhang LL, Xia YF and Zhang YJ: Primary site and
regional lymph node involvement are independent prognostic factors
for early-stage extranodal nasal-type natural killer/T cell
lymphoma. Chin J Cancer. 35:342016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Balachandran VP, Gonen M, Smith JJ and
DeMatteo RP: Nomograms in oncology: More than meets the eye. Lancet
Oncol. 16:e173–e180. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Miao DL, Song W, Qian J, Zhu ZG, Wu Q, Lv
CG and Chen L: Development and validation of a nomogram for
predicting overall survival in pancreatic neuroendocrinetumors.
Transl Oncol. 11:1097–1103. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hayashi Y, Xiao L, Suzuki A, Blum MA,
Sabloff B, Taketa T, Maru DM, Welsh J, Lin SH, Weston B, et al: A
nomogram associated with high probability of malignant nodes in the
surgical specimen after trimodality therapy of patients with
oesophageal cancer. Eur J Cancer. 48:3396–3404. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gold JS, Gönen M, Gutiérrez A, Broto JM,
García-del-Muro X, Smyrk TC, Maki RG, Singer S, Brennan MF,
Antonescu CR, et al: Development and validation of a prognostic
nomogram for recurrence-free survival after complete surgical
resection of localised primary gastrointestinal stromal tumour: A
retrospective analysis. Lancet Oncol. 10:1045–1052. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang JX, Song W, Chen ZH, Wei JH, Liao
YJ, Lei J, Hu M, Chen GZ, Liao B, Lu J, et al: Prognostic and
predictive value of a microRNA signature in stage II colon cancer:
A microRNA expression analysis. Lancet Oncol. 14:1295–1306. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kattan MW, Karpeh MS, Mazumdar M and
Brennan MF: Postoperative nomogram for disease-specific survival
after an R0 resection for gastric carcinoma. J Clin Oncol.
21:3647–3650. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zivanovic O, Jacks LM, Iasonos A, Leitao
MM Jr, Soslow RA, Veras E, Chi DS, Abu-Rustum NR, Barakat RR,
Brennan MF and Hensley ML: A nomogram to predict postresection
5-year overall survival for patients with uterine leiomyosarcoma.
Cancer. 118:660–669. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang Y, Zhang YJ, Zhu Y, Cao JZ, Yuan ZY,
Xu LM, Wu JX, Wang W, Wu T, Lu B, et al: Prognostic nomogram for
overall survival in previously untreated patients with extranodal
NK/T-cell lymphoma, nasal-type: A multicenter study. Leukemia.
29:1571–1577. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cao J, Lan S, Shen L, Si H, Xiao H, Yuan
Q, Li X, Li H and Guo R: Hemoglobin level, a prognostic factor for
nasal extranodal natural killer/T-cell lymphoma patients from stage
I to IV: A validated prognostic nomogram. Sci Rep. 7:109822017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu QF, Wang WH, Wang SL, Liu YP, Huang
WT, Lu N, Zhou LQ, Ouyang H, Jin J and Li YX: Immunophenotypic and
clinical differences between the nasal and extranasal subtypes of
upper aerodigestive tract natural killer/T-cell lymphoma. Int J
Radiat Oncol Biol Phys. 88:806–813. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fang H, Jin J, Wang WH, Wang SL, Zhou LQ
and Li YX: Prognostic factors and treatment outcomes for patients
with stage II extranodal nasal-type natural killer/T-cell lymphoma
of the upper aerodigestive tract. Leuk Lymphoma. 55:1832–1837.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huang MJ, Jiang Y, Liu WP, Li ZP, Li M,
Zhou L, Xu Y, Yu CH, Li Q, Peng F, et al: Early or up-front
radiotherapy improved survival of localized extranodal NK/T-cell
lymphoma, nasal-type in the upper aerodigestive tract. Int J Radiat
Oncol Biol Phys. 70:166–174. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Avilés A, Delgado S, Ruiz H, de la Torre
A, Guzman R and Talavera A: Treatment of non-Hodgkin's lymphoma of
Waldeyer's ring: Radiotherapy versus chemotherapy versus combined
therapy. Eur J Cancer B Oral Oncol 32B. 19–23. 1996. View Article : Google Scholar
|
|
39
|
You JY, Chi KH, Yang MH, Chen CC, Ho CH,
Chau WK, Hsu HC, Gau JP, Tzeng CH, Liu JH, et al: Radiation therapy
versus chemotherapy as initial treatment for localized nasal
natural killer (NK)/T-cell lymphoma: A single institute survey in
Taiwan. Ann Oncol. 15:618–625. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Song G, Xiong GY, Fan Y, Huang C, Kang YM,
Ji GJ, Chen JC, Xin ZC and Zhou LQ: The role of tumor size,
ultrasonographic findings, and serum tumor markers in predicting
the likelihood of malignant testicular histology. Asian J Androl.
21:196–200. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang QS, Zhao SH, Jiang Y, Jiang TY, Yuan
SZ and Su H: Retrospective analysis of clinical features and
prognosis of 84 patients with extranodal NK/T cell lymphoma in one
center. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 25:1390–1396. 2017.(In
Chinese). PubMed/NCBI
|
|
42
|
Wang KF, Chang BY, Chen XQ, Liu PP, Wuxiao
ZJ, Wang ZH, Li S, Jiang WQ and Xia ZJ: A prognostic model based on
pretreatment platelet lymphocyte ratio for stage IE/IIE upper
aerodigestive tract extranodal NK/T cell lymphoma, nasal type. Med
Oncol. 31:3182014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Dai W, Jia B, Yang J, Zhou S, Liu P, He X,
Qin Y, Gui L, Zhang C, Han X, et al: Development of new prognostic
model based on pretreatment βLRI and LLRI for stage IE/IIE upper
aerodigestive tract ENKTL, nasal type. Oncotarget. 8:34787–34795.
2017.PubMed/NCBI
|
|
44
|
Wang GB, Xu GL, Luo GY, Shan HB, Li Y, Gao
XY, Li JJ and Zhang R: Primary intestinal non-Hodgkin's lymphoma: A
clinicopathologic analysis of 81 patients. World J Gastroenterol.
17:4625–4631. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang S, Wang L, Yu D, Shen Y, Cheng S,
Zhang L, Qian Y, Shen Z, Li Q and Zhao W: Localized primary
gastrointestinal diffuse large B cell lymphoma received a surgical
approach: An analysis of prognostic factors and comparison of
staging systems in 101 patients from a single institution. World J
Surg Oncol. 13:2462015. View Article : Google Scholar : PubMed/NCBI
|
